NuCana (NCNA) Competitors $3.86 +0.19 (+5.18%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$3.94 +0.09 (+2.20%) As of 09/12/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NCNA vs. BON, PBLA, TRVN, VINC, NAVB, SYRS, SMFL, VRPX, SCPS, and ARDSShould you be buying NuCana stock or one of its competitors? The main competitors of NuCana include Bon Natural Life (BON), Panbela Therapeutics (PBLA), Trevena (TRVN), Vincerx Pharma (VINC), Navidea Biopharmaceuticals (NAVB), Syros Pharmaceuticals (SYRS), Smart for Life (SMFL), Virpax Pharmaceuticals (VRPX), Scopus BioPharma (SCPS), and Aridis Pharmaceuticals (ARDS). These companies are all part of the "pharmaceutical products" industry. NuCana vs. Its Competitors Bon Natural Life Panbela Therapeutics Trevena Vincerx Pharma Navidea Biopharmaceuticals Syros Pharmaceuticals Smart for Life Virpax Pharmaceuticals Scopus BioPharma Aridis Pharmaceuticals Bon Natural Life (NYSE:BON) and NuCana (NASDAQ:NCNA) are both small-cap pharmaceutical products companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, valuation, earnings, risk, dividends, analyst recommendations, profitability and media sentiment. Do insiders & institutionals hold more shares of BON or NCNA? 0.6% of Bon Natural Life shares are owned by institutional investors. Comparatively, 44.0% of NuCana shares are owned by institutional investors. 26.5% of Bon Natural Life shares are owned by insiders. Comparatively, 31.2% of NuCana shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Does the media refer more to BON or NCNA? In the previous week, Bon Natural Life and Bon Natural Life both had 1 articles in the media. NuCana's average media sentiment score of 1.89 beat Bon Natural Life's score of 0.00 indicating that NuCana is being referred to more favorably in the news media. Company Overall Sentiment Bon Natural Life Neutral NuCana Very Positive Is BON or NCNA more profitable? Bon Natural Life's return on equity of 0.00% beat NuCana's return on equity.Company Net Margins Return on Equity Return on Assets Bon Natural LifeN/A N/A N/A NuCana N/A -592.28%-208.68% Which has better valuation and earnings, BON or NCNA? Bon Natural Life has higher revenue and earnings than NuCana. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBon Natural Life$23.84M0.01$400KN/AN/ANuCanaN/AN/A-$24.28M-$646.16-0.01 Which has more risk and volatility, BON or NCNA? Bon Natural Life has a beta of -0.46, suggesting that its stock price is 146% less volatile than the S&P 500. Comparatively, NuCana has a beta of 1.38, suggesting that its stock price is 38% more volatile than the S&P 500. SummaryBon Natural Life and NuCana tied by winning 4 of the 8 factors compared between the two stocks. Get NuCana News Delivered to You Automatically Sign up to receive the latest news and ratings for NCNA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NCNA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NCNA vs. The Competition Export to ExcelMetricNuCanaMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$111K$3.19B$5.84B$10.14BDividend YieldN/A2.30%5.68%4.60%P/E Ratio-0.0121.4375.4125.98Price / SalesN/A429.44515.81181.13Price / CashN/A46.6837.5660.44Price / Book0.019.6112.156.29Net Income-$24.28M-$53.29M$3.29B$271.07M7 Day Performance34.49%0.13%0.74%3.87%1 Month Performance-6.99%5.55%5.00%5.49%1 Year Performance-99.24%10.44%62.53%25.86% NuCana Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NCNANuCana1.5712 of 5 stars$3.86+5.2%N/A-99.2%$111KN/A-0.0130Positive NewsBONBon Natural LifeN/A$2.01+30.5%N/A-95.8%$317K$23.84M0.00100Gap UpHigh Trading VolumePBLAPanbela Therapeutics0.0669 of 5 stars$0.05-66.7%N/AN/A$243KN/A0.006TRVNTrevena1.6841 of 5 stars$0.25flat$5.00+1,900.0%-95.8%$240K$443K-0.0140Gap UpVINCVincerx Pharma3.2917 of 5 stars$0.04+38.2%$40.00+88,986.9%-99.7%$235KN/A0.0060Short Interest ↓NAVBNavidea BiopharmaceuticalsN/A$0.00flatN/A-50.0%$50K$8.13K0.0010SYRSSyros Pharmaceuticals4.2738 of 5 stars$0.00-50.0%$1.00+90,809.1%-99.9%$30K$386K0.00120Short Interest ↓Gap DownSMFLSmart for LifeN/A$0.00+17.6%N/A-100.0%$28K$11.11M0.00110Gap DownVRPXVirpax Pharmaceuticals0.1818 of 5 stars$0.01-9.8%N/AN/A$14KN/A0.007Gap DownSCPSScopus BioPharmaN/A$0.00-25.0%N/AN/A$13KN/A0.009ARDSAridis PharmaceuticalsN/A$0.00-60.0%N/AN/A$11KN/A0.0030Gap DownHigh Trading Volume Related Companies and Tools Related Companies Bon Natural Life Competitors Panbela Therapeutics Competitors Trevena Competitors Vincerx Pharma Competitors Navidea Biopharmaceuticals Competitors Syros Pharmaceuticals Competitors Smart for Life Competitors Virpax Pharmaceuticals Competitors Scopus BioPharma Competitors Aridis Pharmaceuticals Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NCNA) was last updated on 9/14/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredApple’s falling behindApple just posted record-breaking results, yet its stock barely moved — because in today’s market, investors o...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NuCana PLC Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share NuCana With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
